The US pharmaceutical giant Merck Sharp & Dohme (MSD) s China branch announced on Wednesday that, to meet the needs of Chinese patients and help China s fight against COVID-19, MSD launched licensing negotiations with Sinopharm to manufacture and supply molnupiravir in China.
China is in talks with Pfizer Inc to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the U.S. firm s COVID-19 antiviral drug Paxlovid in. | January 6, 2023
HONG KONG/BEIJING – China is in talks with Pfizer Inc to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the US firm's Covid-19 antiviral drug Paxlovid in China, three sources told Reuters. China's medical products regulator – the National Medical Products Administration (NMPA) – has been leading the talks with Pfizer since.
China in talks with Pfizer for generic COVID drug bdnews24.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bdnews24.com Daily Mail and Mail on Sunday newspapers.